Comparing non-invasive blood pressure measurements to invasive methods in critical care patients
Official title: Non-Invasive Blood Pressure Validation Study
Run by Philips Clinical & Medical Affairs Global · NCT05673408 · Data updated 2026-11-12
This study is testing a new non-invasive blood pressure device to see if it gives accurate readings compared to the standard invasive method in critical care patients of all ages.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 189 (estimated) |
| Sponsor | Philips Clinical & Medical Affairs Global Industry-sponsored |
| Locations | 5 sites (Jacksonville, Florida and 4 other locations) |
| Status | Recruiting |
| Started | June 23, 2023 |
| Main results expected | March 31, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT05673408 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients admitted to intensive care units or operating rooms who require blood pressure monitoring and have an indication for both NIBP cuff and radial arterial line.
✕Probably not a fit
Patients who may not benefit include those with anatomical conditions preventing proper placement of the study device or those with specific cardiac conditions that could interfere with accurate measurements.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the validity of the Philips non-invasive blood pressure (NIBP) system by comparing its measurements to those obtained from an invasive radial arterial line in critical care settings. It will involve multiple centers and will assess various age groups, including neonates, children, and adults, to establish equivalence with the gold standard arterial line. The study will collect data from a predefined number of subjects and data points to ensure robust results.
Why it matters
Potential benefit: If successful, this study could provide a reliable non-invasive method for monitoring blood pressure in critical care patients, potentially improving patient comfort and safety.
How similar studies have gone: Other studies have shown success in validating non-invasive blood pressure monitoring technologies, suggesting that this approach is promising and not entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient admitted into the NICU, PICU, ICU, or OR (operating room) * Adult aged 18 years and older, or parent/legal guardian of minor, willing and able to understand and provide informed consent/assent * Indication for NIBP cuff * Indication for radial arterial line for Subject Group 2 and Subject Group 3, and radial or umbilical arterial line for Subject Group 1 * Meet the following stratification criteria across the study: Stratification (per the ISO 81060-2:2018/Amd-2:2024): * Subject Group 1: * At least 3 patients shall be \<1000 g in weight * At least 3 patients shall be 1000 to 2000 g in weight * At least 3 patients shall be \> 2000 g in weight * At least 3 patients shall be ≥ 29 days and \< 1 year of age * At least 3 patients shall be ≥ 1 year and \< 3 years of age * The remaining patients may be from any of the above age or weight groups in order to complete the sample size * A patient can be in more than one category simultaneously * Subject Group 2: * At least 30% male, 30% female * Limb circumference distributed as specified in ISO81060-2:2018/Amd2:2024. * Subject Group 3: * At least 30% male, 30% female * Limb circumference distributed as specified in ISO81060- 2:2018/Amd-2:2024. * At least 10% SBP ≤ 100mmHg * At least 10% SBP ≥ 160mmHg * At least 10% DBP ≤ 70mmHg * At least 10% DBP ≥ 85mmHg Exclusion Criteria: * Inability to place the study device appropriately due to patient's anatomy or condition * Known pregnancy or lactating women (self-report) * Patients treated with an intra-aortic balloon pump * Aortic and mitral regurgitation (\> 2 nd degree) * Measurements taken in the lateral position * Currently participating in another clinical trial with any product, treatment and/or medication that clinically interferes with the study endpoint(s) * If valid SBP reference measurements for lateral difference is \> 15 mmHg (except for neonates with umbilical A-line) * If valid DBP reference measurements for lateral difference is \> 10 mmHg (except for neonates with umbilical A-line) * At the Principal Investigator's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above
Where it's running
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States Recruiting -
Oregon Health & Science University
Portland, Oregon, United States Recruiting -
University Health Women's and Children's Hospital
San Antonio, Texas, United States Recruiting -
Mayo Clinic Jacksonville
Jacksonville, Florida, United States Completed -
University of Utah
Salt Lake City, Utah, United States Terminated
Study contacts
- Study coordinator: Natalie Hernandez, MBA
- Email: natalie.hernandez@philips.com
- Phone: 210-517-4405
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.